Clinical Trials
3 trialsNCT06915025 2026-06-02
OVATION-3
Imunon
Phase 3 Recruiting
NCT07024784 2026-06-02
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
AbbVie
Phase 2 Recruiting
NCT03740165 2026-05-04
KEYLYNK-001
Merck Sharp & Dohme LLC
Phase 3 Completed